|
1
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee Y, Ahn C, Han J, et al: The nuclear
RNase III Drosha initiates microRNA processing. Nature.
425:415–419. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yi R, Qin Y, Macara IG and Cullen BR:
Exportin-5 mediates the nuclear export of pre-microRNAs and short
hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yekta S, Shih IH and Bartel DP:
MicroRNA-directed cleavage of HOXB8 mRNA. Science. 304:594–596.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hildebrandt-Eriksen ES, Aarup V, Persson
R, Hansen HF, Munk ME and Orum H: A locked nucleic acid
oligonucleotide targeting microRNA 122 is well-tolerated in
cynomolgus monkeys. Nucleic Acid Ther. 22:152–161. 2012.PubMed/NCBI
|
|
7
|
Elmén J, Lindow M, Schutz S, et al:
LNA-mediated microRNA silencing in non-human primates. Nature.
452:896–899. 2008.PubMed/NCBI
|
|
8
|
Heitz F, Morris MC and Divita G: Twenty
years of cell-penetrating peptides: from molecular mechanisms to
therapeutics. Br J Pharmacol. 157:195–206. 2009.PubMed/NCBI
|
|
9
|
Zatsepin TS, Turner JJ, Oretskaya TS and
Gait MJ: Conjugates of oligonucleotides and analogues with cell
penetrating peptides as gene silencing agents. Curr Pharm Des.
11:3639–3654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Andaloussi S, Holm T and Langel U:
Cell-penetrating peptides: mechanisms and applications. Curr Pharm
Des. 11:3597–3611. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Joliot A and Prochiantz A: Transduction
peptides: from technology to physiology. Nat Cell Biol. 6:189–196.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Torchilin VP: Tat peptide-mediated
intracellular delivery of pharmaceutical nanocarriers. Adv Drug
Deliv Rev. 60:548–558. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deshayes S, Morris M, Heitz F and Divita
G: Delivery of proteins and nucleic acids using a non-covalent
peptide-based strategy. Adv Drug Deliv Rev. 60:537–547. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deshayes S, Morris MC, Divita G and Heitz
F: Cell-penetrating peptides: tools for intracellular delivery of
therapeutics. Cell Mol Life Sci. 62:1839–1849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Snyder EL and Dowdy SF: Recent advances in
the use of protein transduction domains for the delivery of
peptides, proteins and nucleic acids in vivo. Expert Opin Drug
Deliv. 2:43–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eguchi A and Dowdy SF: siRNA delivery
using peptide transduction domains. Trends Pharmacol Sci.
30:341–345. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simeoni F, Morris MC, Heitz F and Divita
G: Insight into the mechanism of the peptide-based gene delivery
system MPG: implications for delivery of siRNA into mammalian
cells. Nucleic Acids Res. 31:2717–2724. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoo JW, Hong SW, Kim S and Lee DK:
Inflammatory cytokine induction by siRNAs is cell type- and
transfection reagent-specific. Biochem Biophys Res Commun.
347:1053–1058. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crombez L, Charnet A, Morris MC,
Aldrian-Herrada G, Heitz F and Divita G: A non-covalent
peptide-based strategy for siRNA delivery. Biochem Soc Trans.
35:44–46. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lundberg P, El-Andaloussi S, Sutlu T,
Johansson H and Langel U: Delivery of short interfering RNA using
endosomolytic cell-penetrating peptides. FASEB J. 21:2664–2671.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simeoni F, Morris MC, Heitz F and Divita
G: Peptide-based strategy for siRNA delivery into mammalian cells.
Methods Mol Biol. 309:251–260. 2005.PubMed/NCBI
|
|
22
|
Morris MC, Chaloin L, Méry J, Heitz F and
Divita G: A novel potent strategy for gene delivery using a single
peptide vector as a carrier. Nucleic Acids Res. 27:3510–3517. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morris KV, Chan SW, Jacobsen SE and Looney
DJ: Small interfering RNA-induced transcriptional gene silencing in
human cells. Science. 305:1289–1292. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen QN, Chavli RV, Marques JT, et al:
Light controllable siRNAs regulate gene suppression and phenotypes
in cells. Biochim Biophys Acta. 1758:394–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Esau C, Davis S, Murray SF, et al: miR-122
regulation of lipid metabolism revealed by in vivo antisense
targeting. Cell Metab. 3:87–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu GT, Carrazana EJ, Macklis JD and
Mikati MA: Delayed oculogyric crises associated with
striatocapsular infarction. J Clin Neuroophthalmol. 11:198–201.
1991.PubMed/NCBI
|
|
27
|
Esau CC: Inhibition of microRNA with
antisense oligonucleotides. Methods. 44:55–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lanford RE, Hildebrandt-Eriksen ES, Petri
A, et al: Therapeutic silencing of microRNA-122 in primates with
chronic hepatitis C virus infection. Science. 327:198–201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Méry J, Granier C, Juin M and Brugidou J:
Disulfide linkage to polyacrylic resin for automated Fmoc peptide
synthesis. Immunochemical applications of peptide resins and
mercaptoamide peptides. Int J Pept Protein Res. 42:44–52.
1993.PubMed/NCBI
|
|
30
|
Salonpää P, Pelkonen O, Kojo A, Pasanen M,
Negishi M and Raunio H: Cytochrome P4502A5 expression and
inducibility by phenobarbital is modulated by cAMP in mouse primary
hepatocytes. Biochem Biophys Res Commun. 205:631–637.
1994.PubMed/NCBI
|
|
31
|
Dong J, Guo H, Yang R, et al: Serum LDL-
and HDL-cholesterol determined by ultracentrifugation and HPLC. J
Lipid Res. 52:383–388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Krützfeldt J, Rajewsky N, Braich R, et al:
Silencing of microRNAs in vivo with ‘antagomirs’. Nature.
438:685–689. 2005.
|
|
33
|
Crombez L, Morris MC, Heitz F and Divita
G: A non-covalent peptide-based strategy for ex vivo and in vivo
oligonucleotide delivery. Methods Mol Biol. 764:59–73. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Crombez L, Morris MC, Dufort S, et al:
Targeting cyclin B1 through peptide-based delivery of siRNA
prevents tumour growth. Nucleic Acids Res. 37:4559–4569. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jones S and Howl J: Applications of
cell-penetrating peptides as signal transduction modulators for the
selective induction of apoptosis. Methods Mol Biol. 683:291–303.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kimber MJ, McKinney S, McMaster S, Day TA,
Fleming CC and Maule AG: flp gene disruption in a parasitic
nematode reveals motor dysfunction and unusual neuronal sensitivity
to RNA interference. FASEB J. 21:1233–1243. 2007. View Article : Google Scholar : PubMed/NCBI
|
